Ferrer Internacional Articles
Positive EU regulatory news for Alexza and Ferrer, but not Gentium
22 February 2013
Janssen files for EU approval of canagliflozin in type 2 diabetes; Ferrer pulls Egrifta MAA
27 June 2012
Showing 1-4 of 4 articles
- 1
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
